|
Name |
Sydowic acid, (+)-
|
| Molecular Formula | C15H20O4 | |
| IUPAC Name* |
3-hydroxy-4-[(2R)-2,6,6-trimethyloxan-2-yl]benzoic acid
|
|
| SMILES |
C[C@@]1(CCCC(O1)(C)C)C2=C(C=C(C=C2)C(=O)O)O
|
|
| InChI |
InChI=1S/C15H20O4/c1-14(2)7-4-8-15(3,19-14)11-6-5-10(13(17)18)9-12(11)16/h5-6,9,16H,4,7-8H2,1-3H3,(H,17,18)/t15-/m1/s1
|
|
| InChIKey |
PPKSRWBBMMEDGG-OAHLLOKOSA-N
|
|
| Synonyms |
Sydowic acid, (R)-; Sydowic acid, (+)-; 8UAK634V59; 3-Hydroxy-4-((2R)-tetrahydro-2,6,6-trimethyl-2H-pyran-2-yl)benzoic acid; Benzoic acid, 3-hydroxy-4-((2R)-tetrahydro-2,6,6-trimethyl-2H-pyran-2-yl)-; Benzoic acid, 3-hydroxy-4-(tetrahydro-2,6,6-trimethyl-2H-pyran-2-yl)-, (R)-; 120442-16-2; (+)-Sydowic acid; R)-(+)-sydowic acid; (R)-(+)-sydowic acid; UNII-8UAK634V59; CHEMBL4519267
|
|
| CAS | 120442-16-2 | |
| PubChem CID | 11737144 | |
| ChEMBL ID | CHEMBL4519267 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 264.32 | ALogp: | 2.4 |
| HBD: | 2 | HBA: | 4 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 66.8 | Aromatic Rings: | 2 |
| Heavy Atoms: | 19 | QED Weighted: | 0.845 |
| Caco-2 Permeability: | -4.804 | MDCK Permeability: | 0.00002190 |
| Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.011 |
| 30% Bioavailability (F30%): | 0.018 |
| Blood-Brain-Barrier Penetration (BBB): | 0.062 | Plasma Protein Binding (PPB): | 89.83% |
| Volume Distribution (VD): | 0.475 | Fu: | 12.24% |
| CYP1A2-inhibitor: | 0.033 | CYP1A2-substrate: | 0.804 |
| CYP2C19-inhibitor: | 0.042 | CYP2C19-substrate: | 0.066 |
| CYP2C9-inhibitor: | 0.201 | CYP2C9-substrate: | 0.27 |
| CYP2D6-inhibitor: | 0.02 | CYP2D6-substrate: | 0.118 |
| CYP3A4-inhibitor: | 0.053 | CYP3A4-substrate: | 0.125 |
| Clearance (CL): | 3.159 | Half-life (T1/2): | 0.874 |
| hERG Blockers: | 0.039 | Human Hepatotoxicity (H-HT): | 0.373 |
| Drug-inuced Liver Injury (DILI): | 0.942 | AMES Toxicity: | 0.014 |
| Rat Oral Acute Toxicity: | 0.056 | Maximum Recommended Daily Dose: | 0.012 |
| Skin Sensitization: | 0.118 | Carcinogencity: | 0.063 |
| Eye Corrosion: | 0.008 | Eye Irritation: | 0.811 |
| Respiratory Toxicity: | 0.028 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002280 | ![]() |
1.000 | D0N0RU | ![]() |
0.344 | ||
| ENC005925 | ![]() |
0.695 | D0C4YC | ![]() |
0.290 | ||
| ENC004192 | ![]() |
0.609 | D01CKY | ![]() |
0.290 | ||
| ENC004190 | ![]() |
0.569 | D01WJL | ![]() |
0.290 | ||
| ENC004186 | ![]() |
0.565 | D0D0GV | ![]() |
0.272 | ||
| ENC004350 | ![]() |
0.431 | D07HBX | ![]() |
0.258 | ||
| ENC000002 | ![]() |
0.404 | D0W6DG | ![]() |
0.253 | ||
| ENC000296 | ![]() |
0.383 | D04BCW | ![]() |
0.253 | ||
| ENC001626 | ![]() |
0.373 | D03XES | ![]() |
0.250 | ||
| ENC001090 | ![]() |
0.358 | D0BA6T | ![]() |
0.250 | ||